Medical Mycology

Papers
(The H4-Index of Medical Mycology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches89
Update onCandida krusei, a potential multidrug-resistant pathogen63
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)62
On the lineage of Aspergillus fumigatus isolates in common laboratory use56
CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris50
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation30
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group28
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification27
COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City25
Ebselen and diphenyl diselenide against fungal pathogens: A systematic review23
Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center23
High detection rate of azole-resistantAspergillus fumigatusafter treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low 22
Clinical characteristics and risk factors for COVID-19-associated Candidemia21
Emerging and future strategies in the management of recalcitrant Candida auris21
Filamentous growth is a general feature of Candida auris clinical isolates20
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan20
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients20
Aspergillosis: Emerging risk groups in critically ill patients18
A review of recent research on antifungal agents against dermatophyte biofilms18
0.055163860321045